Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,930Revenue $M70.3Net Margin (%)-207.9Z-Score12.6
Enterprise Value $M7,605EPS $-2.7Operating Margin %-188.9F-Score4
P/E(ttm))0Cash Flow Per Share $-2.3Pre-tax Margin (%)-208.5Higher ROA y-yN
Price/Book22.410-y EBITDA Growth Rate %0Quick Ratio6.9Cash flow > EarningsY
Price/Sales60.15-y EBITDA Growth Rate %0Current Ratio7.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-43.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-108.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M108ROI % (ttm)-54.2Gross Margin Increase y-yY

Gurus Latest Trades with ITMN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ITMNMario Gabelli 2014-09-30 Buy 0.02%$40.59 - $73.91
($56.72)
$ 73.8930%New holding, 60000 sh.60,000
ITMNJoel Greenblatt 2014-09-30 Sold Out $40.59 - $73.91
($56.72)
$ 73.8930%Sold Out0
ITMNPRIMECAP Management 2014-09-30 Sold Out -0.22%$40.59 - $73.91
($56.72)
$ 73.8930%Sold Out0
ITMNJoel Greenblatt 2014-06-30 Buy $26.59 - $47.22
($36.7)
$ 73.89101%New holding, 6487 sh.6,487
ITMNPRIMECAP Management 2014-06-30 Reduce-0.08%$26.59 - $47.22
($36.7)
$ 73.89101%Reduce -31.71%4,525,925
ITMNPRIMECAP Management 2013-03-31 Add0.03%$8.39 - $10.74
($9.55)
$ 73.89674%Add 77.69%5,643,289
ITMNPRIMECAP Management 2012-03-31 Add0.04%$12.35 - $16.64
($13.76)
$ 73.89437%Add 177.48%2,907,700
ITMNPRIMECAP Management 2011-09-30 Add0.01%$20.78 - $37.15
($28.35)
$ 73.89161%Add 31.54%983,900
ITMNPRIMECAP Management 2011-06-30 Add0.01%$32.71 - $51.08
($40.18)
$ 73.8984%Add 53.28%748,000
ITMNGeorge Soros 2011-06-30 Sold Out $32.71 - $51.08
($40.18)
$ 73.8984%Sold Out0
ITMNGeorge Soros 2011-03-31 Buy 0.07%$35.09 - $47.13
($39.54)
$ 73.8987%New holding, 125000 sh.125,000
ITMNPRIMECAP Management 2010-12-31 Add0.02%$12.53 - $38.05
($17.08)
$ 73.89333%Add 108.13%466,000
ITMNPRIMECAP Management 2010-06-30 Add$8.58 - $48.04
($22.74)
$ 73.89225%Add 1013.93%223,900
ITMNAndreas Halvorsen 2010-06-30 Sold Out -0.11%$8.58 - $48.04
($22.74)
$ 73.89225%Sold Out0
ITMNGeorge Soros 2010-06-30 Sold Out -0.01%$8.58 - $48.04
($22.74)
$ 73.89225%Sold Out0
ITMNAndreas Halvorsen 2010-03-31 Buy 0.11%$12.95 - $47.25
($21.68)
$ 73.89241%New holding, 226400 sh.226,400
ITMNGeorge Soros 2010-03-31 Buy 0.01%$12.95 - $47.25
($21.68)
$ 73.89241%New holding, 10705 sh.10,705
ITMNPRIMECAP Management 2010-03-31 Buy $12.95 - $47.25
($21.68)
$ 73.89241%New holding, 20100 sh.20,100
ITMNBill Gates 2009-06-30 Sold Out -0.02%$10.75 - $17.05
($13.21)
$ 73.89459%Sold Out0
ITMNJean-Marie Eveillard 2007-12-31 Sold Out -0.02%$13.37 - $20
($16.8)
$ 73.89340%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ITMN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ITMN Mario Gabelli 2014-09-3060,0000.060.02New Buy
ITMN PRIMECAP Management 2014-09-30000Sold Out
ITMN Joel Greenblatt 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ITMN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Powell Andrew Kenneth WilliamEVP, GC & Secretary 2014-09-02Sell7,500$73.470.57view
Di Nepi GiacomoEVP Managing Director, Europe 2014-08-15Sell22,085$44.9964.24view
ARATA PAUL DEVP, Human Resources & Admin 2014-08-13Sell7,500$5047.78view
Nolan Sean P.EVP & CBO 2014-08-13Sell17,000$5047.78view
HODGMAN JOHNEVP, Finance & CFO 2014-08-11Sell4,724$43.0571.64view
WELCH DANIEL GChairman, CEO and President 2014-08-07Sell171,025$44.9864.27view
ARATA PAUL DEVP, Human Resources & Admin 2014-07-17Sell2,382$4180.22view
Leff Jonathan AEVP, Research & Development 2014-07-15Sell35,000$43.0871.52view
Nolan Sean P.EVP & CBO 2014-06-18Sell10,000$47.156.88view
WELCH DANIEL GChairman, CEO and President 2014-06-16Sell15,000$45.0264.13view

Press Releases about ITMN :

    Quarterly/Annual Reports about ITMN:

    News about ITMN:

    Articles On GuruFocus.com
    Mario Gabelli Comments on InterMune Inc Oct 28 2014 
    Roche to Acquire InterMune and Deliver Hope to Patients Worldwide Aug 25 2014 
    How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
    Weekly CEO Sells Highlight: Protective Life Corp, Western Refining Inc, InterMune Inc, and Tableau S Aug 18 2014 
    Weekly Insider Sells Highlight: BX, PCYC, MAS, ITMN Mar 03 2014 
    11 Mar 07 2012 
    WEEKLY CFO SELLS HIGHLIGHT: ITMN, DISCA, WEC, EMAN, WTW, CAH May 22 2011 
    InterMune Inc. (ITMN) Chairman, CEO and President Daniel G Welch sells 44,000 Shares Mar 04 2011 
    InterMune Inc. Reports Operating Results (10-Q) Nov 08 2010 
    InterMune Inc. Reports Operating Results (10-Q) Aug 09 2010 

    More From Other Websites
    Goldman Sachs beats earnings estimates Oct 16 2014
    Roche, Boehringer Drugs Wins Approval for Lung Disease Oct 15 2014
    INTERMUNE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Sep 29 2014
    Roche purchases shares in tender offer for InterMune, Inc. Sep 29 2014
    InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action Sep 19 2014
    Roche's $8 billion InterMune buy not a signal for more big deals Sep 16 2014
    [video] Cramer: ACAD and ISIS have room to run Sep 11 2014
    INTERMUNE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 05 2014
    InterMune Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015 Sep 05 2014
    Lifshitz & Miller Law Firm Announces Investigation of China Housing & Land Development, Inc., Cobra... Sep 02 2014
    What You Need to Know About the Roche-InterMune Deal Aug 29 2014
    Cramer: Sector could be hotbed of 'bolt-on' deals Aug 28 2014
    InterMune drug may offer big upside to Roche if aimed at liver Aug 27 2014
    InterMune Stockholders Encouraged to Contact Securities Law Firm about Takeover Aug 27 2014
    INTERMUNE SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the... Aug 27 2014
    INTERMUNE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating the Board of Directors of InterMune,... Aug 27 2014
    Roche, InterMune a Strategic Play in Midst of Inversions Aug 27 2014
    The Zacks Analyst Blog Highlights: Roche, InterMune, Achillion Pharmaceuticals, Puma Biotechnology... Aug 27 2014
    INVESTOR ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of... Aug 26 2014
    Celgene, Gilead Lead Big Biotech Stock Movers Aug 26 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK